Rohto Pharmaceutical Co Financial Overview
Rohto Pharmaceutical Co's market cap is currently ¥593.17B. The company's EPS TTM is ¥26.03; its P/E ratio is 16.21; and it has a dividend yield of 1.60%. Rohto Pharmaceutical Co is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ¥38.81. See an overview of income statement, balance sheet, and cash flow financials.
